Profile: Ev3, Inc. is a medical device company that focuses on catheter based or endovascular, technologies for the minimally invasive treatment of vascular diseases and disorders. We offer neuro products such as embolic coils, liquid embolics, micro catheters, Guidewires, balloons, carotoid stents & embolic protection. Our protege everflex stents are intended as a palliative treatment of malignant neoplasms in the biliary tree. Our SpideRX™ embolic protection device has the ability to use a separate, preferred guidewire to cross the lesion and a pre-loaded nitinol filter with a dual-ended catheter for delivery & recovery.

The company was founded in 2000, has revenues of USD 10-25 Million, has ~240 employees. NASDAQ:EVVV (SEC Filings)

FDA Registration Number: 2029214

51 to 52 of 52 Products/Services (Click for related suppliers)  Page: 1 [2]

• Urological Percutaneous Catheters and Sets

• Vascular Device for Promoting Embolization (FDA Code: KRD / 870.3300)